Phenylphosphonic Acid

Phenylphosphonic Acid

SCHEMBL109136

O=P([O-])([O-])c1ccccc1.[Zn+2]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.50
CA4 P22748 1/20 0.50
CA5A P35218 1/20 0.50
CFTR P13569 1/20 0.44
ALDH1A1 P00352 4/20 0.42
GAA P10253 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MAPT P10636 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALPG P10696 1/20 0.42
ALOX12 P18054 1/20 0.42
NPY1R P25929 1/20 0.42
HTT P42858 1/20 0.42
NPY2R P49146 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 2/20 0.41
ALOX15 P16050 1/20 0.41
USP2 O75604 1/20 0.41
ESR1 P03372 1/20 0.41
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylphosphonic Acid SCHEMBL31448304 0.97 CA2 (0.48) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL11086093 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL11099517 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL20140613 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL649333 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL15795006 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL664829 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL912521 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL7951123 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1
Phenylphosphonic Acid SCHEMBL11806110 0.94 CA2 (0.50) CA2CA4CA5ACFTRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080498-A Preparation method of composite nucleating agent for nylon 66 2026-05-26 CN claimed
US-12630710-B1 1,5-pentanediol-based polyester compositions with enhanced crystallization rates and methods of manufacture THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2026-05-19 US claimed
CN-121572670-A Composite acetic acid plate and production method thereof 金华市鑫美饰品有限公司 2026-02-27 CN claimed
CN-119371795-A Preparation method of orthopedic brace based on bamboo fiber filled PLA material 浙江师范大学 2025-01-28 CN claimed
CN-119278204-A Method for producing zinc phenylphosphonate, powder of zinc phenylphosphonate, use thereof as crystallization nucleating agent and moisture-curable hot-melt polyurethane resin binder DIC株式会社 2025-01-07 CN claimed
CN-119256050-A Composition containing zinc phenylphosphonate and zinc phosphate complex, process for its production, its use as crystallization nucleating agent and moisture-curable hot-melt polyurethane resin binder DIC株式会社 2025-01-03 CN claimed
CN-114181522-B Alcoholysis-resistant heat-stable PPA composite material and preparation method thereof 横店集团得邦工程塑料有限公司 2024-08-09 CN claimed
CN-118085528-A High-heat-resistance high-flow modified polylactic acid material and preparation method thereof 陕西煤业化工技术研究院有限责任公司 2024-05-28 CN claimed
WO-2024055237-A1 COMPOSITION CONTAINING PHENYLPHOSPHONIC ACID ZINC SALT AND ZINC PHOSPHATE COMPLEX, METHOD FOR PRODUCING THE SAME, USE OF THE SAME AS CRYSTAL NUCLEATING AGENT, AND MOISTURE-CURABLE HOTMELT URETHANE RESIN ADHESIVE DIC CORPORATION (JP) 2024-03-21 WO claimed
WO-2024055238-A1 METHOD FOR PRODUCING PHENYLPHOSPHONIC ACID ZINC SALT, POWDER OF PHENYLPHOSPHONIC ACID ZINC SALT, USE OF THE SAME AS CRYSTAL NUCLEATING AGENT, AND MOISTURE-CURABLE HOTMELT URETHANE RESIN ADHESIVE DIC CORPORATION (JP) 2024-03-21 WO claimed
US-8829121-B2 Piezoelectric polymer material and method for producing same MITSUI CHEMICALS, INC. (JP) 2014-09-09 US claimed
EP-2220150-B1 METHODS FOR FORMING MICROPOROUS AND ANTIMICROBIAL ARTICLES 3M INNOVATIVE PROPERTIES CO (US) 2013-11-06 EP claimed
US-20130096194-A1 ANTIMICROBIAL ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-04-18 US claimed
EP-2469618-A1 MACROMOLECULAR PIEZOELECTRIC MATERIAL AND MANUFACTURING METHOD THEREFOR Mitsui Chemicals, Inc. (JP) 2012-06-27 EP claimed
US-20120132846-A1 PIEZOELECTRIC POLYMER MATERIAL AND METHOD FOR PRODUCING SAME A SCHOOL CORPORATION KANSAI UNIVERSITY (JP) 2012-05-31 US claimed
JP-2011504945-A 2011-02-17 JP claimed
US-20100258977-A1 Methods for Forming Microporous and Antimicrobial Articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-10-14 US claimed
EP-2220150-A1 METHODS FOR FORMING MICROPOROUS AND ANTIMICROBIAL ARTICLES 3M Innovative Properties Company (US) 2010-08-25 EP claimed
WO-2009070630-A1 METHODS FOR FORMING MICROPOROUS AND ANTIMICROBIAL ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-06-04 WO claimed
US-4219607-A High voltage insulating compositions containing phosphorus compounds RAYCHEM CORPORATION (US) 1980-08-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630710-B1 1,5-pentanediol-based polyester compositions with enhanced crystallization rates and methods of manufacture GRIN2D, SMCHD1, GRIN2C CA2 55/4885CA4 416/4885CA5A 2023/4885
US-20130096194-A1 ANTIMICROBIAL ARTICLES NOP2, SPOUT1, MSN CA2 2447/4885CA4 2981/4885CA5A 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.